1. 1. Shaw AT, Kim DW, Nakagawa K, et al. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med 368: 2385-2394, 2013.
2. 2. Solomon BJ, Mok T, Kim DW, et al. First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med 371: 2167-2177, 2014.
3. 3. Koizumi T, Fukushima T, Tatai T, et al. Successful treatment of crizotinib-induced dysgeusia by switching to alectinib in ALK-positive non-small cell lung cancer. Lung Cancer 88: 112-113, 2015.
4. 4. Yoneshima Y, Okamoto I, Takano T, et al. Successful treatment with alectinib after crizotinib-induced esophageal ulceration. Lung Cancer 88: 349-351, 2015.
5. 5. Kim MS, Kook EH, Ahn SH, et al. Gastrointestinal metastasis of lung cancer with special emphasis on a long-term survivor after operation. J Cancer Res Clin Oncol 135: 297-301, 2009.